SLGL
Sol-Gel Technologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$63.93
+0.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 152.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.35x
- Price / sales
- 116.61x
- Price / cash flow
- 650.02x
Enterprise value
- Enterprise value
- $162.1M
- EV / sales
- 90.33x
- EV / EBITDA
- -9.33x
- EV / EBIT
- -9.15x
- Market cap
- $209.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026